17 August 2023

Eden Research

("Eden" or "the Company")

Result of General Meeting and Capital Raising update

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, is pleased to announce that all resolutions put forward to shareholders at the Company's General Meeting held earlier today were duly passed.

The total number of votes received by proxy on each resolution, as more fully disclosed in the Notice of Meeting available on the Company's website, was as follows:

Notes:

·    * Denotes a Special Resolution.

·    A vote Withheld is not a vote in law and is not counted in the calculation of the votes cast For or Against the resolution, nor in the calculation of the percentage of issued share capital voted for any resolution.

·    Votes For and Against are expressed as a percentage of votes validly cast for that resolution by proxy, excluding any Withheld votes.

Capital Raising update

In the announcement made by the Company on 28 July 2023 regarding its Capital Raising, it was stated that "The Placing of the Conditional Placing Shares is conditional, inter alia, on (i) the approval of the Resolutions at the General Meeting, (ii) the Advanced Assurance being obtained from HMRC, (iii) the Capital Reduction becoming effective and (iv) Second Admission."

In addition to the Resolutions having been approved at the General Meeting today, the Company is pleased to confirm that it has also obtained the Advanced Assurance from HMRC required for the Conditional Placing.

The expected timetable for the satisfying the remaining conditions of the Conditional Placing is as follows:

For further information contact: